Nifar
Brand names,
Nifar
Analogs
Nifar
Brand Names Mixture
Nifar
Chemical_Formula
C17H18N2O6
Nifar
RX_link
http://www.rxlist.com/cgi/generic2/nifedip.htm
Nifar
fda sheet
Nifar
msds (material safety sheet)
Nifar
Synthesis Reference
Bossert, Vater, U.S. Pat. 3,485,847 (1969)
Nifar
Molecular Weight
346.335 g/mol
Nifar
Melting Point
172 - 174 oC
Nifar
H2O Solubility
Insoluble
Nifar
State
Solid
Nifar
LogP
2.343
Nifar
Dosage Forms
Capsule; Tablet; Tablet (extended-release)
Nifar
Indication
For the management of vasospastic angina, chronic stable angina and hypertension.
Nifar
Pharmacology
Nifedipine, the prototype of the dihydropyridine class of calcium-channel antagonists, is similar to other dihydropyridines including amlodipine, felodipine, isradipine, and nicardipine. Nifedipine is used to treat Prinzmetal's angina, hypertension, and other vascular disorders such as Raynaud's phenomenon. By blocking the calcium channels, Nifedipine inhibits the spasm of the coronary artery and dilates the systemic arteries, results in a increase of myocardial oxygen supply and a decrease in systemic blood pressure.
Nifar
Absorption
Rapidly and fully absorbed following oral administration.
Nifar
side effects and Toxicity
Symptoms of overdose include dizziness, drowsiness, nausea, severe drop in blood pressure, slurred speech, and weakness. LD50=494 mg/kg (orally in mice); LD50=1022 mg/kg (orally in rats)
Nifar
Patient Information
Nifar
Organisms Affected
Humans and other mammals